For Patients Customer Login Newsletter Sign-up Home News Physicians Technology Company Investors Contact Profile Governance Presentations TACT Data Webcasts Financial Press Releases Analyst Coverage Subscribe Company Profile Profound Medical Corp. is a medical technology company focused on a therapeutics platform that provides the precision of real-time Magnetic Resonance Imaging combined with the safety and ablation power of directional and focused ultrasound technology for the incision-free ablation of diseased tissue. Profound Medical is publicly traded on TSX (PRN) and on NASDAQ (PROF). Head Office 2400 Skymark Avenue, Unit 6 Mississauga, ON Canada L4W 5K5 Investor Relations Stephen Kilmer Investor Relations skilmer@profoundmedical.com 647.872.4849 (Canada) 646.274.3580 (U.S) Aaron Davidson SVP of Corporate Development info@profoundmedical.com 647.476.1350 Governance Board Of Directors Committee Charters Certificates and Articles of Incorporation Code of Business Conduct Majority Voting Policy & Board Mandate Position Description Presentations TITLE Investor Presentation TULSA-PRO Procedure Video TULSA-PRO Case (Axial Image) Video TACT Data DOCUMENT TACT Data press release TACT Data presentation Webcasts Jefferies London Healthcare Conference – November 18, 2021 Q3 2021 Financial Results Conference Call Webcast – November 4, 2021 Cantor Virtual Global Healthcare Conference – September 30, 2021 Q2 2021 Financial Results Conference Call Webcast – August 4, 2021 Virtual Raymond James Human Health Innovations Conference – June 22, 2021 Jefferies Virtual Healthcare Conference – June 1, 2021 Annual Shareholders Meeting Presentation – May 19, 2021 Q1 2021 Financial Results Conference Call Webcast – May 12, 2021 Bloom Burton & Co. Healthcare Investor Conference April 21, 2021 Cowen 41st Annual Health Care Conference March 4, 2021 Raymond James 42nd Annual Institutional Investors Conference – March 3, 2021 Q4 & Full Year 2020 Financial Results Conference Call Webcast – March 2, 2021 BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference – February 18, 2021 Jefferies Virtual London Healthcare Conference – November 17, 2020 Q3 2020 Financial Results Conference Call Webcast – November 05, 2020 00:00 00:00 Cantor Virtual Global Healthcare Conference – September 17, 2020 Canaccord Genuity 40th Annual Growth Conference – August 13, 2020 Q2 2020 Financial Results Conference Call Webcast – August 6, 2020 00:00 00:00 Q1 2020 Finance Results Conference Call Webcast – May 7,2020 00:00 00:00 Discussion Hosted by Raymond James Research Department – March 26,2020 Cowen and Company 40th Annual Health Care Conference – March 4,2020 Q4 and Full Year 2019 Financial Results Conference Call Webcast – March 3, 2020 BioTuesdays Pre-JPM Virtual Conference- December 10, 2019 Canaccord Genuity 13th Annual Medical Technologies & Diagnostics Forum- November 21, 2019 Stifel 2019 Healthcare Conference – November 20, 2019 Q3 2019 Financial Results Conference Call Webcast – November 7, 2019 00:00 00:00 Q2 2019 Financial Results Recording – August 14, 2019 00:00 00:00 Canaccord Genuity 39th Annual Growth Conference – August 7,2019 Q1 2019 Financial Results Recording – May 6, 2019 00:00 00:00 Bloom Burton & Co. Healthcare Conference – April 30,2019 Profound Medical Analyst Day – April 11,2019 Cowen and Company 39th Annual Health Care Conference – March 13,2019 Q4 and Full Year 2018 Financial Results Recording – March 7, 2019 00:00 00:00 Canaccord Genuity Medical Technologies & Diagnostics Forum – November 15, 2018 Stifel 2018 Healthcare Conference – November 14, 2018 Q3 2018 Financial Results Recording – November 09, 2018 00:00 00:00 Canaccord Genuity 38th Annual Growth Conference – August 8, 2018 Q2 2018 Financial Results Recording – August 14, 2018 00:00 00:00 Q1 2018 Financial Results Recording – May 10, 2018 00:00 00:00 Q4 & Full Year 2017 Financial Results Recording – March 26, 2018 00:00 00:00 Financial Reports, SEDAR and SEC Filings YEAR FINANCIAL STATEMENTS MD&A ANNUAL INFORMATION FORM MANAGEMENT INFORMATION CIRCULAR 2021 Q1 | Q2 | Q3 | FY Q1 | Q2| Q3| FY PDF PDF 2020 Q1 | Q2 | Q3 | FY Q1 | Q2 | Q3 | FY PDF PDF 2019 Q1 | Q2 | Q3 | FY Q1 | Q2 | Q3 | FY PDF PDF 2018 Q1 | Q2 | Q3 | FY Q1 | Q2 | Q3 | FY PDF PDF 2017 Q1 | Q2 | Q3 | FY Q1 | Q2 | Q3 | FY PDF PDF 2016 Q1 | Q2 | Q3 | FY Q1 | Q2 | Q3 | FY PDF PDF 2015 Q1 | Q2 | Q3 | FY Q1 | Q2 | Q3 | FY PDF PDF Access SEDAR Filing Access SEC Filing Press Releases 2021 2020 2019 2018 2017 2016 2015 Analyst Coverage FIRM ANALYST EMAIL Alliance Global Partners Benjamin Haynor bhaynor@allianceg.com Cowen Joshua Jennings, M.D. josh.jennings@cowen.com Jefferies Anthony Petrone apetrone@jefferies.com Lake Street Capital Markets Frank Takkinen frank.takkinen@lakestreetcm.com Leed Jones Gable Doug Loe dloe@leedejonesgable.com Paradigm Capital Scott McAuley smcauley@paradigmcap.com Raymond James Rahul Sarugaser rahul.sarugaser@raymondjames.ca Research Capital Andre Uddin auddin@researchcapital.com Subscribe To receive financial information via email, please complete this form; Your Name * Your Email * Company Country 106728B CAUTION: Products shown may not be approved for sale in all jurisdictions. Rx only device. Contact us at info@profoundmedical.com for more information regarding the regulatory status of the device. News Single center retrospective analysis of fifty-two prostate cancer patients with customized MR-guided transurethral ultrasound ablation (TULSA) October 4, 2021 Read more SONALLEVE WEBINAR: May 12th 2021 March 5, 2021 Read more TULSA-PRO WEBINAR: April 1st 2021 February 25, 2021 Read more Careers & Training Careers Customer Login TULSA-PRO Training Head Office Profound Medical Corp., 2400 Skymark Avenue, Unit #6, Mississauga, ON L4W 5K5, Canada T: 647.476.1350 F: 647.847.3739 info@profoundmedical.com Newsletter Sign Up © Copyright - Profound Medical 2021 Home Physicians TULSA PRO Patients Company News Investors Contact Customer Login TULSA-PRO Training Privacy Policy By continuing to browse the site, you are agreeing to our use of cookies.OKLearn More